Journal of Medical Ethics (6):2012-101300 (2013)

Authors
David M. Shaw
University of Basel
Abstract
One of the most fascinating issues in the emerging field of neuroethics is pharmaceutical cognitive enhancement (CE). The three main ethical concerns around CE were identified in a Nature commentary in 2008 as safety, coercion and fairness; debate has largely focused on the potential to help those who are cognitively disabled, and on the issue of “cosmetic neurology”, where people enhance not because of a medical need, but because they want to (as many as 25% of American students already use nootropic cognitive enhancers such as ritalin). However, the potential for CE to improve public health has been neglected. This paper examines the prospect of improving health outcomes through cognitive enhancement among sections of the population where health inequalities are particularly pronounced. I term this enhancement of the public's health through CE “neuroenhancing health”. It holds great promise, but raises several ethical issues. This paper provides an outline of these issues and related philosophical problems. These include the potential effectiveness of CE in reducing health inequalities; issues concerning autonomy and free will; whether moral enhancement might be more effective than cognitive enhancement in reducing health inequalities; and the problem of how to provide such CE, including the issue of whether to provide targeted and universal coverage.
Keywords Neuroenhancement  Health inequalities  Cognitive enhancement
Categories (categorize this paper)
DOI 10.1136/medethics-2012-101300
Options
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy


Upload a copy of this paper     Check publisher's policy     Papers currently archived: 53,688
External links

Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
Through your library

References found in this work BETA

Neuroenhancers, Addiction and Research Ethics.David Martin Shaw - 2012 - Journal of Medical Ethics 38 (10):605-608.

Add more references

Citations of this work BETA

Add more citations

Similar books and articles

Broadening the Bioethics Agenda.Dan W. Brock - 2000 - Kennedy Institute of Ethics Journal 10 (1):21-38.
Public Health and Public Goods.Jonny Anomaly - 2011 - Public Health Ethics 4 (3):251-259.
Enhancement Technologies and Professional Integrity.Franklin G. Miller & Howard Brody - 2005 - American Journal of Bioethics 5 (3):15 – 17.

Analytics

Added to PP index
2013-06-08

Total views
22 ( #453,075 of 2,349,560 )

Recent downloads (6 months)
3 ( #239,179 of 2,349,560 )

How can I increase my downloads?

Downloads

My notes